Organizational Factors As Predictors of Tobacco Cessation Pharmacotherapy Adoption in Addiction Treatment Programs

Overview

Journal J Addict Med

Specialty Psychiatry

Date 2013 Dec 25

PMID 24365803

Citations 19

Authors

Jessica L Muilenburg

Tanja C Laschober

Lillian T Eby

Affiliations

Soon will be listed here.

Abstract

Objectives: This study investigated 3 organizational factors (ie, counseling staff clinical skills, absence of treatment program obstacles, and policy-related incentives) as predictors of tobacco cessation pharmacotherapy (TCP) adoption (comprised of the 9 available TCPs) in addiction treatment programs using the innovation implementation effectiveness framework.

Methods: Data were obtained in 2010 from a random sample of 1006 addiction treatment program administrators located across the United States using structured telephone interviews.

Results: According to program administrator reports, TCP is adopted in approximately 30% of treatment programs. Negative binomial regression results show that fewer treatment program obstacles and more policy-related incentives are related to greater adoption of TCP. Counter to prediction, clinical skills are unrelated to TCP adoption.

Conclusions: Our findings suggest that organizational factors, on the basis of established theoretical frameworks, merit further examination as facilitators of the adoption of diverse TCP in addiction treatment programs.

Citing Articles

Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff.

Campbell B, Le T, McCuistian C, Hosakote S, Kapiteni K, Guydish J Drug Alcohol Depend Rep. 2023; 2:100033.

PMID: 36845887 PMC: 9948912. DOI: 10.1016/j.dadr.2022.100033.

An evaluation of the feasibility of implementing a novel tobacco dependence treatment program for high-risk individuals into clinical practice within a community mental health center.

Hogan T, Quisenberry A, Breitborde N, Moe A, Ferketich A Int J Ment Health Syst. 2022; 16(1):15.

PMID: 35184758 PMC: 8858522. DOI: 10.1186/s13033-022-00517-y.

Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.

Taing M, Nitturi V, Chen T, Kyburz B, Martinez Leal I, Correa-Fernandez V Int J Environ Res Public Health. 2022; 19(1).

PMID: 35010499 PMC: 8744608. DOI: 10.3390/ijerph19010239.

Nicotine and Opioids: a Call for Co-treatment as the Standard of Care.

Morris C, Garver-Apgar C J Behav Health Serv Res. 2020; 47(4):601-613.

PMID: 32495248 PMC: 7269614. DOI: 10.1007/s11414-020-09712-6.

Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Vlad C, Arnsten J, Nahvi S CNS Drugs. 2020; 34(4):367-387.

PMID: 32107731 PMC: 7609040. DOI: 10.1007/s40263-020-00701-z.

References

Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A . Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011; 13(6):401-11. PMC: 3103720. DOI: 10.1093/ntr/ntr048. View

Clarke J, Stein M, McGarry K, Gogineni A . Interest in smoking cessation among injection drug users. Am J Addict. 2001; 10(2):159-66. DOI: 10.1080/105504901750227804. View

Weiner B, Lewis M, Linnan L . Using organization theory to understand the determinants of effective implementation of worksite health promotion programs. Health Educ Res. 2008; 24(2):292-305. DOI: 10.1093/her/cyn019. View

Rohsenow D, Monti P, Colby S, Gulliver S, Swift R, Abrams D . Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine Tob Res. 2003; 5(2):231-6. DOI: 10.1080/1462220031000073298. View

Fuller B, Guydish J, Tsoh J, Reid M, Resnick M, Zammarelli L . Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2006; 32(1):53-60. PMC: 3496385. DOI: 10.1016/j.jsat.2006.06.011. View

Friedmann P, Jiang L, Richter K . Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2007; 34(2):165-72. PMC: 3689419. DOI: 10.1016/j.jsat.2007.02.006. View

Hurt R, Offord K, Croghan I, Kottke T, Morse R, Melton 3rd L . Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996; 275(14):1097-103. DOI: 10.1001/jama.275.14.1097. View

Hays J, Schroeder D, Offord K, Croghan I, Patten C, Hurt R . Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 2000; 21(3):244-50. DOI: 10.1007/BF02884841. View

Rieckmann T, Kovas A, McFarland B, Abraham A . A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. J Subst Abuse Treat. 2011; 41(4):374-85. PMC: 3486698. DOI: 10.1016/j.jsat.2011.05.005. View

10.

Choi J, Chang J . Innovation implementation in the public sector: an integration of institutional and collective dynamics. J Appl Psychol. 2009; 94(1):245-53. DOI: 10.1037/a0012994. View

11.

Ziedonis D, Guydish J, Williams J, Steinberg M, Foulds J . Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2007; 29(3):228-35. PMC: 6527042. View

12.

Knudsen H, Ducharme L, Roman P, Link T . Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat. 2005; 29(2):95-106. DOI: 10.1016/j.jsat.2005.05.002. View

13.

Breslau N, Peterson E, Schultz L, Andreski P, Chilcoat H . Are smokers with alcohol disorders less likely to quit?. Am J Public Health. 1996; 86(7):985-90. PMC: 1380440. DOI: 10.2105/ajph.86.7.985. View

14.

Richter K, Ahluwalia H, Mosier M, Nazir N, Ahluwalia J . A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002; 97(7):861-9. DOI: 10.1046/j.1360-0443.2002.00162.x. View

15.

Ellingstad T, Sobell L, Sobell M, Cleland P, Agrawal S . Alcohol abusers who want to quit smoking: implications for clinical treatment. Drug Alcohol Depend. 1999; 54(3):259-65. DOI: 10.1016/s0376-8716(98)00180-x. View

16.

Schoenwald S, Sheidow A, Chapman J . Clinical supervision in treatment transport: effects on adherence and outcomes. J Consult Clin Psychol. 2009; 77(3):410-21. PMC: 2762701. DOI: 10.1037/a0013788. View

17.

Knudsen H, Studts J . Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation. Drug Alcohol Depend. 2011; 118(2-3):244-50. PMC: 3150224. DOI: 10.1016/j.drugalcdep.2011.03.028. View

18.

Rothrauff T, Eby L . Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. Am J Addict. 2010; 20(1):56-62. PMC: 3677156. DOI: 10.1111/j.1521-0391.2010.00095.x. View

19.

Ratschen E, Britton J, Doody G, Leonardi-Bee J, McNeill A . Tobacco dependence, treatment and smoke-free policies: a survey of mental health professionals' knowledge and attitudes. Gen Hosp Psychiatry. 2009; 31(6):576-82. DOI: 10.1016/j.genhosppsych.2009.08.003. View

20.

Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D . Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2009; 30(1):12-24. PMC: 2826972. DOI: 10.1016/j.cpr.2009.08.009. View